NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Maybe some of the experts can weight in, but it just appears to me that the FDA seems to do more harm than good with these halts. It just seems to me that patients would have more options for treatment, and there would be less pain and suffering, if the FDA were not so punitive in how they respond when an issue comes up in a trial.

I would like to hear from anyone on this board that has worked with or for the FDA, just to get a sense of whether there are some systemic problems at the agency. There just has to be a better way forward with drug approvals.